Completed
A Study of LY3493269 in Participants With Type 2 Diabetes
J1X-MC-GZHC - ClinicalTrials.gov - NCT04515576
The main purpose of this study is to determine the side effects related to LY3493269 in participants with type 2 diabetes.
How long will I be in the trial?
The study will last up to approximately 16 weeks for each participant and may include up to 11 visits.
Completed
A Study of LY3493269 in Participants With Type 2 Diabetes
J1X-MC-GZHC - ClinicalTrials.gov - NCT04515576
The main purpose of this study is to determine the side effects related to LY3493269 in participants with type 2 diabetes.
How long will I be in the trial?
The study will last up to approximately 16 weeks for each participant and may include up to 11 visits.
Key Requirements
Age :
18-70
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18-70
Sex
All
Participants must
Participants must have type 2 diabetes that is under control, and HbA1c of at least 7.0% and no more than 10.5%
Participants must have stable body weight for the last three months
Participants must follow birth control requirements
Participants must NOT
Participants must not have type 1 diabetes
Participants must not have uncontrolled diabetes (meaning that they required hospitalization for treatment of life-threatening complications of diabetes) in the last six months
Participants must not have had more than one episode of severe low blood sugar requiring emergency treatment within the last six months
Participants must not take blood sugar lowering drugs, other than a stable dose of metformin, within the last three months
Participants must not have other serious or unstable illnesses
Participants must not have undergone weight loss surgery (stomach stapling, lapbanding, etc.) or have taken prescription weight loss medicine within the last three months
Participants must not be pregnant or breastfeeding
Trial Summary
Conditions the trial is for
Adult Type 2 Diabetes
What the trial is testing?
LY3493269
Could I receive a Placebo?
yes
Enrollment Goal
56
Trial Dates
August 2020 - March 2021
Trial Phase
1
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18-70
Sex
All
Participants must
Participants must have type 2 diabetes that is under control, and HbA1c of at least 7.0% and no more than 10.5%
Participants must have stable body weight for the last three months
Participants must follow birth control requirements
Participants must NOT
Participants must not have type 1 diabetes
Participants must not have uncontrolled diabetes (meaning that they required hospitalization for treatment of life-threatening complications of diabetes) in the last six months
Participants must not have had more than one episode of severe low blood sugar requiring emergency treatment within the last six months
Participants must not take blood sugar lowering drugs, other than a stable dose of metformin, within the last three months
Participants must not have other serious or unstable illnesses
Participants must not have undergone weight loss surgery (stomach stapling, lapbanding, etc.) or have taken prescription weight loss medicine within the last three months
Participants must not be pregnant or breastfeeding
Trial Summary
Conditions the trial is for
Adult Type 2 Diabetes
What the trial is testing?
LY3493269
Could I receive a Placebo?
yes
Enrollment Goal
56
Trial Dates
August 2020 - March 2021
Trial Phase
1
Not the right fit? Sign up to receive updates on new trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
Adult Type 2 Diabetes Resources
